SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anthem Biosciences - Quaterly Results

13 Aug 2025 Evaluate
A decent increase of about 58.92% in the turnover to Rs. 5380.11 millions was observed for the quarter ended June 2025. The turnover stood at Rs. 3385.39 millions during the similar quarter previous year.The Profit  for the quarter ended June 2025 of  Rs. 1483.41  millions  grew by 73.83% from Rs. 853.36 millions.Operating Profit saw a handsome growth to 2231.57 millions from 1426.84 millions in the quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202506 202406 % Var
Sales 5380.11 3385.39 58.92 5380.11 3385.39 58.92 5380.11 3385.39 58.92
Other Income 277.28 194.55 42.52 277.28 194.55 42.52 277.28 194.55 42.52
PBIDT 2231.57 1426.84 56.40 2231.57 1426.84 56.40 2231.57 1426.84 56.40
Interest 16.06 26.40 -39.17 16.06 26.40 -39.17 16.06 26.40 -39.17
PBDT 2215.51 1400.44 58.20 2215.51 1400.44 58.20 2215.51 1400.44 58.20
Depreciation 226.12 183.38 23.31 226.12 183.38 23.31 226.12 183.38 23.31
PBT 1989.39 1217.06 63.46 1989.39 1217.06 63.46 1989.39 1217.06 63.46
TAX 505.98 363.70 39.12 505.98 363.70 39.12 505.98 363.70 39.12
Deferred Tax 5.29 57.39 -90.78 5.29 57.39 -90.78 5.29 57.39 -90.78
PAT 1483.41 853.36 73.83 1483.41 853.36 73.83 1483.41 853.36 73.83
Equity 1123.22 1118.15 0.45 1123.22 1118.15 0.45 1123.22 1118.15 0.45
PBIDTM(%) 41.48 42.15 -1.59 41.48 42.15 -1.59 41.48 42.15 -1.59

Anthem Biosciences Share Price

739.50 -1.05 (-0.14%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×